Increase in the inflammatory marker GlycA over 13 years in young adults is associated with poorer cognitive function in midlife

PLoS ONE

Volumn 10, Issue 9, 2015, Pages

  Cohen Manheim, Irit ^a   Doniger, Glen M ^b,c   Sinnreich, Ronit ^a   Simon, Ely S ^b,d   Pinchas Mizrachi, Ronit ^a   Otvos, James D ^e   Kark, Jeremy D ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b NeuroTrax Corporation   (Israel)

^c ONO ACADEMIC COLLEGE   (Israel)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^e LABORATORY CORPORATION OF AMERICA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; FIBRINOGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PROTEIN GLYCA; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; AUTACOID;

ADULT; ARTICLE; BLOOD SAMPLING; BODY MASS; COGNITION; COGNITIVE FUNCTION TEST; CONTROLLED STUDY; DEPRESSION; EXECUTIVE FUNCTION; FEMALE; FOLLOW UP; GROUPS BY AGE; HUMAN; INFLAMMATION; LEISURE; LEUKOCYTE COUNT; MALE; OUTCOME ASSESSMENT; PREVALENCE; SMOKING; SMOKING CESSATION; WEIGHT GAIN; YOUNG ADULT; ADOLESCENT; BIOLOGICAL MODEL; BLOOD; CLINICAL TRIAL; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

ADOLESCENT; ADULT; BIOMARKERS; COGNITION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFLAMMATION MEDIATORS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; MODELS, BIOLOGICAL;

EID: 84947740352     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0138036     Document Type: Article

References (52)

1. Gorelick PB. Role of inflammation in cognitive impairment: results of observational epidemiological studies and clinical trials. Ann N Y Acad Sci. 2010;1207:155-62. doi: 10.1111/j.1749-6632.2010. 05726.x PMID: 20955439
2. Tan ZS, Beiser AS, Vasan RS, Roubenoff R, Dinarello CA, Harris TB, et al. Inflammatory markers and the risk of Alzheimer disease: the Framingham Study. Neurology. 2007;68:1902-8. PMID: 17536046
3. Koyama A, O'Brien J, Weuve J, Blacker D, Metti AL, Yaffe K. The role of peripheral inflammatory markers in dementia and Alzheimer's disease: a meta-analysis. J Gerontol A Biol Sci Med Sci. 2013;68:433-40. doi: 10.1093/gerona/gls187 PMID: 22982688
4. Engelhart MJ, Geerlings MI, Meijer J, Kiliaan A, Ruitenberg A, van Swieten JC, et al. Inflammatory proteins in plasma and the risk of dementia: the rotterdam study. Arch Neurol. 2004;61:668-72. PMID: 15148142
5. Dik MG, Jonker C, Hack CE, Smit JH, Comijs HC, Eikelenboom P. Serum inflammatory proteins and cognitive decline in older persons. Neurology. 2005;64:1371-7. PMID: 15851726
6. Alley DE, Crimmins EM, Karlamangla A, Hu P, Seeman TE. Inflammation and rate of cognitive change in high-functioning older adults. J Gerontol A Biol Sci Med Sci. 2008;63:50-5. PMID: 18245760
7. Weuve J, Ridker PM, Cook NR, Buring JE, Grodstein F. High-sensitivity C-reactive protein and cognitive function in older women. Epidemiology. 2006;17:183-9. PMID: 16477259
8. Teunissen CE, van Boxtel MP, Bosma H, Bosmans E, Delanghe J, De Bruijn C, et al. Inflammation markers in relation to cognition in a healthy aging population. J Neuroimmunol. 2003;134:142-50. PMID: 12507782
9. Windham BG, Simpson BN, Lirette S, Bridges J, Bielak L, Peyser PA, et al. Associations between inflammation and cognitive function in african americans and European americans. J Am Geriatr Soc. 2014;62:2303-10. doi: 10.1111/jgs.13165 PMID: 25516026
10. Kao TW, Chang YW, Chou CC, Hu J, Yu YH, Kuo HK. White blood cell count and psychomotor cognitive performance in the elderly. Eur J Clin Invest. 2011;41:513-20. doi: 10.1111/j.1365-2362.2010. 02438.x PMID: 21466549
11. Gimeno D, Marmot MG, Singh-Manoux A. Inflammatory markers and cognitive function in middle-aged adults: the Whitehall II study. Psychoneuroendocrinology. 2008;33:1322-34. doi: 10.1016/j.psyneuen. 2008.07.006 PMID: 18774232
12. Schram MT, Euser SM, de Craen AJ, Witteman JC, Frolich M, Hofman A, et al. Systemic markers of inflammation and cognitive decline in old age. J Am Geriatr Soc. 2007;55:708-16. PMID: 17493190
13. Jefferson AL, Massaro JM, Beiser AS, Seshadri S, Larson MG, Wolf PA, et al. Inflammatory markers and neuropsychological functioning: the Framingham Heart Study. Neuroepidemiology. 2011;37:21-30. doi: 10.1159/000328864 PMID: 21757961
14. Jenny NS, French B, Arnold AM, Strotmeyer ES, Cushman M, Chaves PH, et al. Long-term assessment of inflammation and healthy aging in late life: the Cardiovascular Health Study All Stars. J Gerontol A Biol Sci Med Sci. 2012;67:970-6. doi: 10.1093/gerona/glr261 PMID: 22367431
15. Noble JM, Manly JJ, Schupf N, Tang MX, Mayeux R, Luchsinger JA. Association of C-reactive protein with cognitive impairment. Arch Neurol. 2010;67:87-92. doi: 10.1001/archneurol.2009.308 PMID: 20065134
16. Rafnsson SB, Deary IJ, Smith FB, Whiteman MC, Rumley A, Lowe GD, et al. Cognitive decline and markers of inflammation and hemostasis: the Edinburgh Artery Study. J Am Geriatr Soc. 2007;55:700-7. PMID: 17493189
17. Singh-Manoux A, Dugravot A, Brunner E, Kumari M, Shipley M, Elbaz A, et al. Interleukin-6 and C-reactive protein as predictors of cognitive decline in late midlife. Neurology. 2014;83:486-93. doi: 10.1212/WNL.0000000000000665 PMID: 24991031
18. Rafnsson S, Deary IJ, Whiteman MC, Rumley A, Lowe GD, Fowkes FG. Haemorheological predictors of cognitive decline: the Edinburgh Artery Study. Age Ageing. 2010;39:217-22. doi: 10.1093/ageing/afp227 PMID: 20097662
19. Palta P, Xue QL, Deal JA, Fried LP, Walston JD, Carlson MC. Interleukin-6 and C-reactive protein levels and 9-year cognitive decline in community-dwelling older women: The Women's Health and Aging Study II. J Gerontol A Biol Sci Med Sci. 2014. [Epub ahead of print] doi: 10.1093/gerona/glu132 PMID: 25161214
20. Quinn TJ, Gallacher J, Deary IJ, Lowe GD, Fenton C, Stott DJ. Association between circulating hemostatic measures and dementia or cognitive impairment: systematic review and meta-analyzes. J Thromb Haemost. 2011;9:1475-82. doi: 10.1111/j.1538-7836.2011.04403.x PMID: 21676170
21. Otvos JD, Shalaurova I, Wolak-Dinsmore J, Connelly MA, Mackey RH, Stein JH, et al. GlycA: a composite nuclear magnetic resonance biomarker of systemic inflammation. Clin Chem. 2015;61:714-23. doi: 10.1373/clinchem.2014.232918 PMID: 25779987
22. de Heredia FP, Gomez-Martinez S, Marcos A. Obesity, inflammation and the immune system. Proc Nutr Soc. 2012;71:332-8. doi: 10.1017/S0029665112000092 PMID: 22429824
23. Rom O, Avezov K, Aizenbud D, Reznick AZ. Cigarette smoking and inflammation revisited. Respir Physiol Neurobiol. 2013;187:5-10. doi: 10.1016/j.resp. 2013.01.013 PMID: 23376061
24. Dowd JB, Haan MN, Blythe L, Moore K, Aiello AE. Socioeconomic gradients in immune response to latent infection. Am J Epidemiol. 2008;167:112-20. PMID: 17873099
25. Slater PE, Friedlander Y, Baras M, Harlap S, Halfon ST, Kaufmann NA, et al. The Jerusalem Lipid Research Clinic: sampling, response and selected methodological issues. Isr J Med Sci. 1982;18:1106-12. PMID: 7161042
26. Kark JD, Sinnreich R, Leitersdorf E, Friedlander Y, Shpitzen S, Luc G. Taq1B CETP polymorphism, plasma CETP, lipoproteins, apolipoproteins and sex differences in a Jewish population sample characterized by low HDL-cholesterol. Atherosclerosis. 2000;151:509-18. PMID: 10924728
27. Kark JD, Goldberger N, Kimura M, Sinnreich R, Aviv A. Energy intake and leukocyte telomere length in young adults. Am J Clin Nutr. 2012;95:479-87. doi: 10.3945/ajcn. 111.024521 PMID: 22237065
28. Dwolatzky T, Whitehead V, Doniger GM, Simon ES, Schweiger A, Jaffe D, et al. Validity of a novel computerized cognitive battery for mild cognitive impairment. BMC Geriatr. 2003;3:4. PMID: 14594456
29. Melton JL. Psychometric evaluation of the Mindstreams neuropsychological screening tool. NEDU Technical Report 06-10, tNavy Experimental Diving Unit, Panama City, FL. 2005.
30. Schweiger A, Dwolatzky T, Jaffe D, Simon ES. Reliability of a novel computerized neuropsychological battery for mild cognitive impairment. Acta Neuropsychologica. 2003;1:407-13.
31. Thaler A, Mirelman A, Gurevich T, Simon E, Orr-Urtreger A, Marder K, et al. Lower cognitive performance in healthy G2019S LRRK2 mutation carriers. Neurology. 2012;79:1027-32. PMID: 22914834
32. Sasson E, Doniger GM, Pasternak O, Tarrasch R, Assaf Y. White matter correlates of cognitive domains in normal aging with diffusion tensor imaging. Front Neurosci. 2013;7:32. doi: 10.3389/fnins. 2013.00032 PMID: 23493587
33. Boussi-Gross R, Golan H, Volkov O, Bechor Y, Hoofien D, Schnaider Beeri M, et al. Improvement of Memory Impairments in Poststroke Patients by Hyperbaric Oxygen Therapy. Neuropsychology. 2014. [Epub ahead of print] doi: 10.1037/neu0000149 PMID: 25384125
34. Hartman SJ, Marinac CR, Natarajan L, Patterson RE. Lifestyle factors associated with cognitive functioning in breast cancer survivors. Psychooncology. 2014. [Epub ahead of print] doi: 10.1002/pon. 3626 PMID: 25073541
35. Zur D, Naftaliev E, Kesler A. Evidence of Multidomain Mild Cognitive Impairment in Idiopathic Intracranial Hypertension. J Neuroophthalmol. 2015;35:26-30. doi: 10.1097/WNO.0000000000000199 PMID: 25383589
36. Kraus V, Schild EO, Hodge RW. Occupational prestige in the collective conscience. Soc Forces. 1978;56:900-18.
37. Burazeri G, Goda A, Sulo G, Stefa J, Kark JD. Financial loss in pyramid savings schemes, downward social mobility and acute coronary syndrome in transitional Albania. J Epidemiol Community Health. 2008;62:620-6. doi: 10.1136/jech.2007.066001 PMID: 18559445
38. Friedewald WT, Levi RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499-502. PMID: 4337382
39. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361-70. PMID: 6880820
40. Sakia RM. The Box-Cox transformation technique: a review. The Statistician. 1992;41:169-78.
41. Rumley A, Emberson JR, Wannamethee SG, Lennon L, Whincup PH, Lowe GD. Effects of older age on fibrin D-dimer, C-reactive protein, and other hemostatic and inflammatory variables in men aged 60-79 years. J Thromb Haemost. 2006;4:982-7. PMID: 16689748
42. Hutchinson WL, Koenig W, Frohlich M, Sund M, Lowe GD, Pepys MB. Immunoradiometric assay of circulating C-reactive protein: age-related values in the adult general population. Clin Chem. 2000;46:934-8. PMID: 10894836
43. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO 3rd, Criqui M, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003;107:499-511. PMID: 12551878
44. Tarkowski E, Rosengren L, Blomstrand C, Wikkelso C, Jensen C, Ekholm S, et al. Intrathecal release of pro- and anti-inflammatory cytokines during stroke. Clin Exp Immunol. 1997;110:492-9. PMID: 9409656
45. Marchesi VT. Alzheimer's dementia begins as a disease of small blood vessels, damaged by oxidativeinduced inflammation and dysregulated amyloid metabolism: implications for early detection and therapy. Faseb j. 2011;25:5-13. doi: 10.1096/fj.11-0102ufm PMID: 21205781
46. Hoshi T, Kitagawa K, Yamagami H, Furukado S, Hougaku H, Hori M. Relations of serum high-sensitivity C-reactive protein and interleukin-6 levels with silent brain infarction. Stroke. 2005;36:768-72. PMID: 15746456
47. Chakrabarty P, Li A, Ceballos-Diaz C, Eddy JA, Funk CC, Moore B, et al. IL-10 alters immunoproteostasis in APP mice, increasing plaque burden and worsening cognitive behavior. Neuron. 2015;85:519-33. doi: 10.1016/j.neuron. 2014.11.020 PMID: 25619653
48. McAfoose J, Baune BT. Evidence for a cytokine model of cognitive function. Neurosci Biobehav Rev. 2009;33:355-66. doi: 10.1016/j.neubiorev. 2008.10.005 PMID: 18996146
49. Wilson CJ, Finch CE, Cohen HJ. Cytokines and cognition-the case for a head-to-toe inflammatory paradigm. J Am Geriatr Soc. 2002;50:2041-56. PMID: 12473019
50. Parsey CM, Schmitter-Edgecombe M. Applications of technology in neuropsychological assessment. Clin Neuropsychol. 2013;27:1328-61. doi: 10.1080/13854046.2013.834971 PMID: 24041037
51. Singh-Manoux A, Kivimaki M, Glymour MM, Elbaz A, Berr C, Ebmeier KP, et al. Timing of onset of cognitive decline: results from Whitehall II prospective cohort study. BMJ. 2012;344:d7622. doi: 10.1136/bmj.d7622 PMID: 22223828
52. Guillot-Sestier MV, Doty KR, Gate D, Rodriguez J Jr, Leung BP, Rezai-Zadeh K, et al. Il10 deficiency rebalances innate immunity to mitigate Alzheimer-like pathology. Neuron. 2015;85:534-48. doi: 10. 1016/j.neuron. 2014.12.068 PMID: 25619654